Evidence mapPaperPMID 41357128Full record

ArticleRSC advances2025

Computational design, synthesis,

Ajay Mili, Sumit Birangal, Krishnadas Nandakumar, Raghu Chandrashekar Hariharapura, Nitesh Kumar, Aravinda Pai, Richard Lobo

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ajay MiliDepartment of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Manipal Karnataka-576104 India.ORCID https://orcid.org/0000-0002-0718-6114
Sumit BirangalDepartment of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Manipal Karnataka-576104 India.
Krishnadas NandakumarDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Manipal Karnataka-576104 India.
Raghu Chandrashekar HariharapuraDepartment of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Manipal Karnataka-576104 India.
Nitesh KumarDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur Bihar-844102 India.
Aravinda PaiDepartment of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Manipal Karnataka-576104 India.
Richard LoboDepartment of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education Manipal Karnataka-576104 India.ORCID https://orcid.org/0000-0003-3202-1108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced liver injury is a major clinical and pharmacological challenge, often driven by oxidative stress and inflammation. This study aimed to develop a sesamol derivative with enhanced hepatoprotective efficacy

Identifiers

PMID41357128
PMCPMC12679566

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.